Cerini C, Geider S, Dussol B, Hennequin C, Daudon M, Veesler S, Nitsche S, Boistelle R, Berthézène P, Dupuy P, Vazi A, Berland Y, Dagorn J C, Verdier J M
INSERM U315, Physiologie et Pathologie Digestives, Hôpital Sainte-Marguerite, Marseille, France.
Kidney Int. 1999 May;55(5):1776-86. doi: 10.1046/j.1523-1755.1999.00426.x.
Urine is supersaturated in calcium oxalate, which means that it will contain calcium oxalate crystals that form spontaneously. Their size must be controlled to prevent retention in ducts and the eventual development of a lithiasis. This is achieved, in part, by specific inhibitors of crystal growth. We investigated whether promoters of crystal nucleation could also participate in that control, because for the same amount of salt that will precipitate from a supersaturated solution, increasing the number of crystals will decrease their average size and facilitate their elimination.
Albumin was purified from commercial sources and from the urine of healthy subjects or idiopathic calcium stone formers. Its aggregation properties were characterized by biophysical and biochemical techniques. Albumin was then either attached to several supports or left free in solution and incubated in a metastable solution of calcium oxalate. Kinetics of calcium oxalate crystallization were determined by turbidimetry. The nature and efficiency of nucleation were measured by examining the type and number of neoformed crystals.
Albumin, one of the most abundant proteins in urine, was a powerful nucleator of calcium oxalate crystals in vitro, with the polymers being more active than monomers. In addition, nucleation by albumin apparently led exclusively to the formation of calcium oxalate dihydrate crystals, whereas calcium oxalate monohydrate crystals were formed in the absence of albumin. An analysis of calcium oxalate crystals in urine showed that the dihydrate form was present in healthy subjects and stone formers, whereas the monohydrate, which is thermodynamically more stable and constitutes the core of most calcium oxalate stones, was present in stone formers only. Finally, urinary albumin purified from healthy subjects contained significantly more polymers and was a stronger promoter of calcium oxalate nucleation than albumin from idiopathic calcium stone formers.
Promotion by albumin of calcium oxalate crystallization with specific formation of the dihydrate form might be protective, because with rapid nucleation of small crystals, the saturation levels fall; thus, larger crystal formation and aggregation with subsequent stone formation may be prevented. We believe that albumin may be an important factor of urine stability.
尿液中草酸钙处于过饱和状态,这意味着尿液中会自发形成草酸钙晶体。必须控制这些晶体的大小,以防止其在管道中滞留并最终发展为结石。这在一定程度上是通过晶体生长的特定抑制剂来实现的。我们研究了晶体成核促进剂是否也能参与这种控制,因为对于从过饱和溶液中沉淀出的相同量的盐,增加晶体数量会减小其平均尺寸并便于其排出。
从商业来源以及健康受试者或特发性钙结石患者的尿液中纯化白蛋白。通过生物物理和生化技术对其聚集特性进行表征。然后将白蛋白附着在几种载体上或使其游离于溶液中,并在草酸钙的亚稳溶液中孵育。通过比浊法测定草酸钙结晶的动力学。通过检查新形成晶体的类型和数量来测量成核的性质和效率。
白蛋白是尿液中最丰富的蛋白质之一,在体外是草酸钙晶体的强力成核剂,聚合物比单体更具活性。此外,白蛋白诱导的成核显然仅导致二水草酸钙晶体的形成,而在没有白蛋白的情况下则形成一水草酸钙晶体。对尿液中草酸钙晶体的分析表明,二水合物形式存在于健康受试者和结石患者中,而热力学上更稳定且构成大多数草酸钙结石核心的一水合物仅存在于结石患者中。最后,从健康受试者中纯化的尿白蛋白含有明显更多的聚合物,并且比特发性钙结石患者的白蛋白更能促进草酸钙成核。
白蛋白促进草酸钙结晶并特异性形成二水合物形式可能具有保护作用,因为小晶体的快速成核会降低饱和度水平;因此,可以防止更大晶体的形成和聚集以及随后的结石形成。我们认为白蛋白可能是尿液稳定性的一个重要因素。